Trial Profile
Observational Study of Early Interferon beta 1-a Treatment in High Risk Subjects after CIS (SET Study)
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 30 Jun 2014
Price :
$35
*
At a glance
- Drugs Interferon beta-1a (Primary)
- Indications Multiple sclerosis
- Focus Therapeutic Use
- Acronyms SET Study
- 30 Jun 2014 New trial record